Meetings/Workshops on Oncology in the United States (USA)

Conference-Service.com offers, as part of our business activities, a directory of upcoming scientific and technical meetings. The calendar is published for the convenience of conference participants and we strive to support conference organisers who need to publish their upcoming events. Although great care is being taken to ensure the correctness of all entries, we cannot accept any liability that may arise from the presence, absence or incorrectness of any particular information on this website. Always check with the meeting organiser before making arrangements to participate in an event!

Meeting organisers can submit meetings free of charge for inclusion into the listing.

1.
 
Oncology Research 2017 — International Conference on Oncology Research
ID
841315
Dates
27 Mar 2017 - 29 Mar 2017
Location
San Antonio, United States
Abstract
Gavin Conferences invites participants from all over the world to attend “International Conference on Oncology Research” during March 27-29, 2017 at San Antonio, Texas, USA. This international conference provides a platform for researchers and decision makers in cancer research to present their latest findings and learn about all the important developments in cancer research.
Contact
Jenny Parker;     Phone: [6303970234];     Email: oncologyresearch@gavinconferences.net
Topics
Clinical Oncologists, Registered Nurses, Nurse practitioners, Cancer Researchers, Radiologists
2.
 
Keystone Symposia - Genomic Instability and DNA Repair
ID
825359
Dates
02 Apr 2017 - 02 Jun 2017
Location
Santa Fe, New Mexico, United States
Abstract
Genome stability is the foundation upon which all cellular and organismal processes depend. This conference will grapple with the intricate array of biochemical reactions orchestrated by the cell to replicate, repair and segregate chromosomes accurately despite constant threats from spontaneous and environmentally-induced damage. Defects in these reactions lead to genomic instability, a confirmed driver of cancer and degenerative diseases. Fascinating and therapeutically crucial questions remain about the mechanisms underlying chromosome stability, and cross-disciplinary approaches are required to address them. How do epigenetic chromatin marks influence repair of underlying DNA sequences, and how can we predict the effects of chemotherapeutic agents that alter such marks? To what extent is the nucleus organized into subdomains with distinct functions; how are these subdomains altered when cells move or differentiate? How are the myriad helicases, nucleases and polymerases coordinated to safeguard genome stability, why are these molecules often mutated in human disease, and how can we ameliorate the effects of such mutations? What is the array of strategies available to cancer cells as they achieve unlimited proliferation? This conference has a history of bringing together investigators from diverse subfields who otherwise rarely meet. Cutting-edge concepts in translational, genomic, cellular, molecular, RNA and structural biology will be dissected to take the conversation to unprecedented levels of depth and breadth. The concurrent conference on “DNA Replication and Recombination” will provide additional opportunities for cross-talk. Both conferences are committed to nurturing interactions among longtime experts in the field with students, postdocs and investigators new to the field.
Contact
Phone: [1 800-253-0685];     Email: info@keystonesymposia.org
Topics
Genomic Instability, DNA Repair, RNA Metabolism, Chromatin Structure, DNA Replication/Repair, Nuclear Dynamics, Cell Cycle Regulation, DNA Damage Response, Replication Coupled Repair, Telomeres, Centromeres
Related subject(s)
3.
 
CancerMetastasis — Cancer Metastasis through the Lymphovascular System: Biology & Treatement, 7th International Symposium
ID
813103
Dates
20 Apr 2017 - 22 Apr 2017
Location
San Francisco, United States
Abstract
This is a very exciting time to be involved in cancer research! The 7th iteration of the Symposium brings together international experts in oncology, immunobiology, pharmacology, molecular biology and molecular imaging to discuss preclinical, translational and clinical advances in diagnosing, treating and preventing cancer metastasis as we enter the era of precision medicine. With advancements in cancer care and patient-centered treatment planning, cancer survivors today live longer and enjoy a vastly improved quality of life than thought imaginable. We hope you will participate in Cancer Metastasis through the Lymphovascular System: Biology & Treatment, 7th International Symposium, scheduled for April 20-22, 2017 in San Francisco, California.
Contact
Joan Oefner;     Phone: [491711049181];     Email: joefner@cancermetastasis.org
Topics
immunotherapy, oncology, breast cancer, melanoma, lymphedema, radiation therapy, metastasis, cancer biology, cancer treatment, cancer microenvironment, tumor, Lymphatic System, molecular biomarkers, Sentinel Lymph Nodes
4.
 
iwCLL — XVII International Workshop on Chronic Lymphocytic Leukemia
ID
823260
Dates
12 May 2017 - 15 May 2017
Location
New York City, United States
Abstract
The International Workshop on Chronic Lymphocytic Leukemia (iwCLL) is a biannual meeting focused solely on advancing the understanding and treatment of chronic lymphocytic leukemia (CLL) and related lymphoproliferative disorders. Founded in 1979, iwCLL is now the largest international meeting dedicated to these blood cancers, leading the scientific discussion on both laboratory-based research and clinical practice. The biannual meeting provides a forum that facilitates the exchange of information and encourages collaboration among international leaders and scientists interested in CLL and other lymphoproliferative disorders.
Contact
Kraig Steubing;     Phone: [1-888-476-9129];     Email: iwcll2017@bioascend.com
Topics
CLL, Lymphoproliferative Disorders
Related subject(s)
5.
 
AAMP Scottsdale — Clinical Chronic Disease & Oncology Conference
ID
880552
Dates
19 May 2017 - 21 May 2017
Location
Scottsdale, United States
Abstract
This 3 day conference is for MDs/NDs and DOs who are looking for advanced information on Integrative Medicine. There are so many conferences that just take you to the “basic level”, but having attended a number of conferences, this audience is for those who want information at the next level that can be applied in their clinical practice. 19.75 AMA PRA Category 1 credits available.
Contact
Sharon Phillips;     Phone: [9545401896];     Email: sharon@aampconferences.com
Topics
Integrative Medicine, chronic illness, genomics, cancer, environmental toxicants, infectious disease, autoimmunity, advanced therapy integration, IV Therapy, Hormonal, Hyperbarics, Diet and Hyperthermia
Related subject(s)
6.
 
FASEB SRC — Mitochondrial Biogenesis and Dynamics in Health, Disease and Aging
ID
876961
Dates
21 May 2017 - 26 May 2017
Location
West Palm Beach, Florida, United States
Abstract
The central role of mitochondria in normal cell physiology is evident from human diseases, including metabolic disorders and aging, which are associated with changes in mitochondrial function. This SRC will facilitate an exchange of knowledge and promote collaborative interactions between investigators that study basic aspects of mitochondria with translational investigators engaged in studying mitochondrial roles in human health, human diseases including age-associated disorders, and the aging process. Hence, this conference will gather basic and translational scientists with a broad range of research interests and different levels of experience ranging from established investigators to graduate students. A collegial format will facilitate discussions between all participants with the goal of bringing together their unique insights and integrate them into this rapidly expanding field.
Contact
FASEB SRC Staff;     Phone: [3016347010];     Email: src@faseb.org
Topics
signaling, cancer, biochem, genetics, aging
7.
 
PMWC 2017 Duke — Precision Medicine World Conference 2017 Duke
ID
880589
Dates
24 May 2017 - 25 May 2017
Location
Durham, United States
Abstract
Co hosted by Stanford Health Care, UCSF, Intermountain Health, Duke University and Duke Health, the Precision Medicine World Conference (PMWC) formerly known as the Personalized Medicine World Conference is the only fully integrated conference to examine the advances and challenges of Personalized Medicine through a practical lens. PMWC brings together the thought-leaders of business, government, healthcare-delivery, research and technology into one information-rich, two-day conference.
Contact
Tomer Behar;     Email: tomer@pmwcintl.com
8.
 
American Society of Clinical Oncology 2017 Annual Meeting
ID
651300
Dates
02 Jun 2017 - 06 Jun 2017
Location
Chicago, United States
Abstract
Attendees of the 2017 Annual Meeting will find cutting-edge scientific presentations and comprehensive educational content. The ASCO Annual Meeting brings together more than 25,000 oncology professionals from a broad range of specialties, making it an excellent venue for exploring the theme of the Meeting — "Science and Society." Prospective attendees can familiarize themselves with some basic information, including: The various session types that will take place at the Annual Meeting, The Cancer Education and Scientific Program Committees.
Event website
9.
 
FASEB SRC — Regulation and Function of Small GTPases
ID
871082
Dates
11 Jun 2017 - 16 Jun 2017
Location
West Palm Beach, Florida, United States
Abstract
This SRC provides an interactive forum that covers the latest developments in the small GTPase field and presents the newest technological advancements that are being used to unravel the complex roles of small GTPases in human health and disease. Small GTPases (e.g. Ras, Rac, Rho, Cdc42, Rab, Rap, Rheb and Ral) are essential for key cellular processes such as cell differentiation, proliferation, and migration, as well as the regulation of subcellular events such as vesicle trafficking. These critical functions of small GTPases make them important participants in a wide variety of physiological and pathophysiological processes. The founding member of the small GTPase superfamily, Ras, is the most commonly mutated oncogene in human cancers, and many other small GTPases (including RhoA, Rac1, Rab5, Rheb, and RalA) also play fundamental roles in cancer development and progression. Due to these important oncogenic functions of small GTPases, there is a strong cancer theme underlying this meeting. However, small GTPases also participate in other biomedically important events, including the promotion of vascular diseases, immunological abnormalities, mental disorders, and metabolic conditions. For these reasons, progress from a number of fields in addition to cancer biology will be highlighted, including neurobiology, developmental biology, computational biology, and membrane biophysics to ensure that we are leveraging and learning from discoveries made in important related fields. The main objective of the meeting is to stimulate cross-pollination of ideas among researchers investigating basic biochemical mechanisms, cell and tissue biology, and translational models to define the diverse functions of small GTPases.
Contact
FASEB SRC Staff;     Phone: [3016347010];     Email: src@faseb.org
Topics
signaling, cell prolif &migration, cancer, physiology, biophysics
Related subject(s)
10.
 
FASEB SRC — GRKs and Arrestins: From Structure to Disease
ID
877032
Dates
11 Jun 2017 - 16 Jun 2017
Location
Saxtons River, VT, United States
Abstract
The overarching goal of the meeting is to bring together as many scientists working on diverse aspects of GRK/arrestin signaling as possible, in order to facilitate the exchange of novel findings and to stimulate the generation of new hypotheses, collaborations and approaches. The structural and functional mechanisms of GRKs and arrestins, as well as their roles in biased/non-canonical signaling by GPCRs, in the actions of drugs of abuse, in cardiovascular disease and in cancer will be major highlights of the meeting. Sessions devoted to these topics will foster further studies to combat addiction and disease with the ultimate objective of positively influencing human health. There are many opportunities available for attendees to give oral and poster presentations as well as optional recreational activities to foster the exchange of ideas and formulate new collaborations.
Contact
FASEB SRC Staff;     Phone: [3016347010];     Email: src@faseb.org
Related subject(s)
11.
 
FASEB SRC — Hematologic Malignancies
ID
876921
Dates
23 Jul 2017 - 28 Jul 2017
Location
Saxtons River, VT, United States
Abstract
This SRC focuses on bringing together biochemists, geneticists, molecular biologists and clinicians interested in the pathophysiology of the leukemias and lymphomas, and the development of novel therapies for these diseases. Leukemia and lymphoma has provided a number of key paradigms for molecularly targeted cancer therapy, as illustrated by the remarkable success of all-trans-retinoic acid for the treatment of acute promyelocytic leukemia and tyrosine kinase inhibitor therapy for chronic myelogenous leukemia. New and promising small-molecule compounds and antibodies targeting epigenetic regulators, surface receptors and downstream signaling pathways are currently under development and will be discussed at this meeting. Added to these examples of targeted therapy, immunotherapy, including checkpoint inhibition and modified T cell-based therapies have emerged as important future anti-leukemia/lymphoma treatments.
Contact
FASEB SRC Staff;     Phone: [3016347010];     Email: src@faseb.org
Topics
cancer, stem cell, hematology, genetics, molecular biology, lymphoma/leukemia
12.
 
FASEB SRC — Reversible Acetylation on Health and Disease (HDACs)
ID
871138
Dates
06 Aug 2017 - 11 Aug 2017
Location
Big Sky, Montana, United States
Abstract
Over the past few years, the “epigenetic” regulation of the genome has become increasingly important to understanding both the etiology and fundamental mechanisms of aging and age-related diseases. Key to epigenetic regulation are two classes of lysine-modifying enzymes, the histone deacetylases (sirtuins and HDACs) and the histone acetyltransferases (HATs). Both classes of enzyme are critical for maintaining youthful gene expression patterns, cell cycle progression, DNA repair, stem cells, mitochondria, cell fate, differentiation, cognition, energy utilization, and the pathogenesis of most age-related diseases. Alterations in sirtuin and HDAC function have been linked to neurodegenerative disorders, muscle wasting, cardiac hypertrophy, cancer, HIV infection, and more generally the process of aging. Several HDAC inhibitors have been approved by FDA to treat various cancers. Small molecule modulators of sirtuins are currently in clinical trials for the treatment of cancers, neuromuscular disorders, inflammatory and metabolic disorders. With particular relevance to aging, the sirtuins, a subclass of HDAC, were first identified in yeast genetic studies as regulators of lifespan and the health benefits of dietary restriction. Activation or overexpression of sirtuins have been shown to protect mice and primates from diseases of aging, and extend mean and maximum lifespan of mice. Therefore, a thorough understanding of sirtuins and HDACs is required, not merely for understanding the regulation of chromatin structure, gene regulation and protein function, but also because these enzymes are intimately involved in normal and abnormal cellular processes that greatly impact human health. Although targeting HATs for therapeutic purposes has been relatively slow compared to targeting deacetylases, exciting new progress has also been made in recent years. Importantly, targeting the bromodomains present in many HATs has attracted a lot of attention lately.
Contact
FASEB SRC Staff;     Phone: [3016347010];     Email: src@faseb.org
Topics
aging, stem cell, cancer, differentiation, structural biology
Related subject(s)
13.
 
ICAHO2017 — International Conference on Advances in Hematology and Oncology
ID
844269
Dates
12 Aug 2017 - 13 Aug 2017
Location
Coeur d'Alene, United States
Abstract
The goal of 5th International Conference on Advances in Hematology and Oncology (ICAHO 2017) is to improve the care of hematology and oncology patients by updating the hematology and oncology care providers about the new developments in the field. This ICAHO 2017 conference also provides attendees with opportunities to interact and network with top experts in hematology and oncology. We will have educational and scientific sessions.
Contact
Tara Shah;     Phone: [3605244696];     Email: support@binayfoundation.org
Topics
Cancer, Blood disease, Cancer research, Hematology, Oncology
Related subject(s)
14.
 
Cancer Conferences, Cancer Meetings, Cancer Symposiums, Cancer Conferences USA — 2nd World Congress on Cancer Research & Therapy
ID
869176
Dates
02 Oct 2017 - 04 Oct 2017
Location
San Diego, United States
Abstract
On Tremendous success of our Cancer Congress-2016, The 2nd World Congress on Cancer Research & Therapy will take place in the gorgeous city of San Diego, USA in October 02-04, 2017 and the theme of the conference is “Aspiration, inspiration and imagination – Cancer research, Treatment and Care”. Cancer Congress-2017 is designed to be a relaxed and friendly meeting where delegates and invited speakers have a chance to interact on both a scientific and social basis. We encourage the speakers to stay for the duration of the conference to ensure this interaction.
Contact
Jason Clark;     Phone: [3373223608];     Email: cancer@innovincconferences.com
Topics
cancer conferences, cancer conferences usa, oncology conferences, cancer meetings, cancer symposiums, cancer nursing meetings, 2nd world congress on cancer, world cancer congress, cancer research conferences, cancer therapy conferences, world cancer research conference
Related subject(s)
15.
 
ICOR 2017 — International Conference on Oncology and Radiology
ID
874910
Dates
23 Oct 2017 - 25 Oct 2017
Location
Las Vegas, United States
Abstract
The (ICOR 2017) Conference on Oncology and Radiology is an International Cancer Conference, a professional association that focuses on research in the field of Oncology. The aim of this association by constitution is to promote research in all fields of Cancer and related sciences, to encourage improvements in methods for the prevention and treatment of Cancer, to improve the health of the public through research, and to facilitate cooperation among investigators and the communication of research findings and their implications throughout the world. Plus, you'll have the opportunity to connect with more than 500 of your peers and celebrate your profession. You'll leave better educated and more invigorated than you thought possible. We wish to see you in Las Vegas, a promising place to discover novel things in the field of science and technology.
Contact
Michal Albert;     Phone: [+1 (702) 988 2320];     Email: cancer@magnusconferences.com
Topics
cancer conference, cancer conferences, cancer conferences 2017, oncology conference, oncology conferences, oncology conferences 2017, radiology conferences, global summit on oncology and radiology, oncology and radiology conferences 2017
Event website
16.
 
Biomarkers Congress 2017 — Annual World Congress on Biomarkers & Clinical Research
ID
884468
Dates
27 Nov 2017 - 28 Nov 2017
Location
Atlanta, United States
Abstract
PULSUS brings in a new spin on conferences by presenting the latest scientific improvements in Biomarkers and its clinical researches. Listen to motivating keynotes from thought leaders, pioneers across the globe. Atlanta is all set for an amazing event as PULSUS proudly presents the “Annual World Congress on Biomarkers & Clinical Research” on November 27-28, 2017. PULSUS cordially welcome researchers, academicians, students and business professionals in the field of BIOMARKERS from around the world to participate in the upcoming BIOMARKERS CONGRESS 2017. The meeting for this year will revolve around the theme “Explore the latest Biomarkers development in health and clinical research” thus relaying the most cutting edge findings in the field of Biomarkers Research.
Contact
Safina Robinson;     Phone: [+1-800-982-0387];     Email: biomarkers@cmesocietyconferences.org
Topics
Biomarker Conference, Biomarkers Conference 2017, Biomarkers Conferences, Biomarkers Congress, Biomarker Conferences USA, Biomarker Conferences, Biomarkers Congress 2017, Biomarker Conferences 2017, Biomarkers Society Conferences, Biomarkers cme conference
17.
 
Cancer Imaging and Therapy
ID
836406
Dates
02 Apr 2018 - 06 Apr 2018
Location
Hollywood, United States
Abstract
The Cancer Imaging and Therapy conference will focus on optical methods in cancer, centered on imaging and treatment of cancer. The conference will accept submissions on topics on the molecular and cellular level, such as reporters and theranostics; on the tissue and pre-clinical (animal) level, such as pathology methods and advances in imaging of tumor models; and on human tissue and living human subjects, when specifically dealing with cancer. More generic biomedical optics and biophotonics research involving human tissues or living human subjects should be submitted to the Clinical and Translational Biophotonics conference at this congress.

View all listed conferences in the United States (USA).

Good to know...

You can advertise your event or services in this space.

Last updated: 19 March 2017